from fierce biotech--
The ambitious effort, called the Accelerating Medicines Partnership, unites Johnson & Johnson ($JNJ), AbbVie ($ABBV), Bristol-Myers Squibb ($BMY), Merck ($MRK), Pfizer ($PFE), Sanofi ($SNY), GlaxoSmithKline ($GSK), Takeda, Biogen Idec ($BIIB) and Eli Lilly ($LLY), plus nonprofits including the American Diabetes Association and the Alzheimer's Association.